Early-stage Lung Cancer
6
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)
A Single-Center, Prospective Phase II Clinical Study of Proton Beam Intensity-Modulated Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Assessing AI for Detecting Lung Nodules and Cancer: Pre- and Post-Deployment Study
Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC
A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.
Detection of Lung Cancer by Plasma Lipids